Oscar Health, Inc. (OSCR)
USD 11.98
(3.23%)
USD 11.98
(3.23%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -270.72 Million USD | 55.59% |
| 2022 | -609.55 Million USD | -6.67% |
| 2021 | -571.42 Million USD | -40.46% |
| 2020 | -406.82 Million USD | -55.76% |
| 2019 | -261.18 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 177.36 Million USD | 218.22% |
| 2024 Q2 | 56.2 Million USD | -68.31% |
| 2023 Q3 | -65.39 Million USD | -321.16% |
| 2023 FY | -270.72 Million USD | 55.59% |
| 2023 Q4 | -150.03 Million USD | -129.41% |
| 2023 Q2 | -15.52 Million USD | 60.82% |
| 2023 Q1 | -39.62 Million USD | 82.51% |
| 2022 Q2 | -112.16 Million USD | -45.06% |
| 2022 Q1 | -77.32 Million USD | 61.13% |
| 2022 FY | -609.55 Million USD | -6.67% |
| 2022 Q4 | -226.56 Million USD | -17.06% |
| 2022 Q3 | -193.54 Million USD | -72.56% |
| 2021 Q4 | -198.92 Million USD | 6.5% |
| 2021 Q3 | -212.74 Million USD | -191.16% |
| 2021 Q2 | -73.06 Million USD | 16.37% |
| 2021 FY | -571.42 Million USD | -40.46% |
| 2021 Q1 | -87.37 Million USD | 53.98% |
| 2020 FY | -406.82 Million USD | -55.76% |
| 2020 Q4 | -189.87 Million USD | -139.94% |
| 2020 Q2 | -40.94 Million USD | 57.74% |
| 2020 Q1 | -96.87 Million USD | 0.0% |
| 2020 Q3 | -79.13 Million USD | -93.27% |
| 2019 FY | -261.18 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cigna Corporation | 5.16 Billion USD | 105.243% |
| Centene Corporation | 2.7 Billion USD | 110.02% |
| CVS Health Corporation | 8.34 Billion USD | 103.245% |
| Elevance Health Inc. | 5.98 Billion USD | 104.522% |
| Humana Inc. | 2.48 Billion USD | 110.877% |
| Molina Healthcare, Inc. | 1.09 Billion USD | 124.815% |
| UnitedHealth Group Incorporated | 22.38 Billion USD | 101.21% |